The Alpha Algorithm Chooses the Bluest of Blue Chips

Nicholas Vardy

Nicholas Vardy has a unique background that has proven his knack for making money in different markets around the world.

This week’s Alpha Algorithm generated a recommendation that many long-term investors just “buy and hold” forever. After all, Johnson & Johnson (JNJ) has not only outperformed the broad-based S&P 500 in 2016, but also over five-year and 10-year periods as well.

Founded in 1885 and based in New Brunswick, New Jersey, Johnson & Johnson manufactures and sells various products in the health care field worldwide. It offers consumer products that have become household names such as Listerine, Tylenol and Sudafed. It also operates in the pharmaceutical and medical devices areas as well.


JNJ (blue) vs. the S&P 500 (red) over one year
JNJ (blue) vs. the S&P 500 (red) over one year

Five Top Investment Strategies Betting on Johnson & Johnson (JNJ)

1. High Quality Stock

Stock exhibits positive fundamentals, including high return on equity, stable year-over-year earnings growth and low financial leverage.

2. Fundamental Strength

A top U.S. stock based on fundamentals measured by book value, cash flow and sales dividends.

3. Dividend Aristocrat

The stock is among those that have increased dividends for at least 25 consecutive years.

4. Hedge Fund Alpha

Based on publicly available disclosures, successful hedge fund managers are investing in the stock.

5. Dividend Dog

It is one of the five highest-yielding stocks among each of the 10 sectors tracked in the S&P 500.


Buy Johnson & Johnson (JNJ) at market today.

Place your initial stop at $102.00.


Since I tend to recommend options only when the stock has pulled back in the midst of an uptrend, I am holding off on recommending options this week.

Exclusive  Has the Market Bottomed?

Like This Article?
Now Get Our FREE Special Report:
Alternative Investing: Investing in Timber

Stock Investor editor Paul Dykewicz reveals why investing in timber may be one of the best long-term portfolio strategies you'll find today.

Get Access to the Report, 100% FREE

previous article

Asian investment analyst Carl Delfeld explains why "frontier" economies are on the move and recommends some promising funds for the sector.


Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details


Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details


Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details


Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details


Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details


Used by financial advisors and individual investors all over the world, is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.